Hyogo, Japan

Kosaburo Sato


Average Co-Inventor Count = 2.6

ph-index = 3

Forward Citations = 33(Granted Patents)


Company Filing History:


Years Active: 1984-1988

Loading Chart...
3 patents (USPTO):Explore Patents

Title: Innovations of Kosaburo Sato

Introduction

Kosaburo Sato is a notable inventor based in Hyogo, Japan. He has made significant contributions to the field of biotechnology, particularly in the development of antiviral and anti-tumor agents. With a total of three patents to his name, Sato's work has had a profound impact on medical science.

Latest Patents

Sato's latest patents include the development of novel interferon alphas, specifically IFN.alpha.S51B10 and IFN.alpha.S17H9. These interferons are prepared from BALL-1 cells induced with Sendai virus, utilizing well-known recombinant DNA techniques. This invention also encompasses a DNA encoding interferon .alpha.S51B10 or .alpha.S17H9, a recombinant plasmid that enables the expression of these interferons in host microorganisms. Both IFN.alpha.s exhibit antiviral and anti-tumor activity, making them valuable as medicines for both humans and animals. Additionally, Sato has developed novel sulfonamido-benzamide derivatives that possess potent antiviral and anti-coccidial activities with low toxicity. These compounds are useful in the prophylaxis and treatment of viral infectious diseases and coccidiosis.

Career Highlights

Kosaburo Sato is associated with Shionogi & Company Limited, where he continues to innovate and contribute to the field of pharmaceuticals. His work has been instrumental in advancing therapeutic options for various diseases.

Collaborations

Sato has collaborated with notable colleagues, including Masaru Ogata and Takao Konishi, to further enhance the impact of his research and inventions.

Conclusion

Kosaburo Sato's contributions to biotechnology and medicine through his innovative patents highlight his role as a leading inventor in the field. His work continues to pave the way for advancements in antiviral and anti-tumor therapies.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…